Retatrutide – Triple-Action Research Peptide

Retatrutide is a research-grade triple-hormone peptide currently being studied for its potential effects on metabolic regulation, weight management, and glucose control. This investigational compound is designed as a once-weekly injectable and replicates the activity of three naturally occurring gut hormones involved in appetite, energy use, and metabolic balance.

For Research Purposes Only — Not for Human Use

Mechanism of Action
Retatrutide simultaneously activates three key hormone receptors, giving it a multi-pathway profile that stands out in current metabolic research:

GLP-1 Receptor
Reduces appetite
Slows gastric emptying
Supports stable glucose levels

GIP Receptor
Enhances GLP-1 activity
Further improves glucose metabolism

Glucagon Receptor
Increases energy expenditure
Promotes calorie utilization